About
CritiSense develops technology for monitoring patients' metabolic state in real time and as an endpoint of resuscitation. CritiSense's first generation product, CritiView, is a patient-monitoring system providing real-time continuous information via four physiological parameters, sensed at the tissue level and reflecting the systemic metabolic state. CritiView provides continuous, real-time, multi-parametric physiological data at the tissue and cellular level by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation. CritiView is an adjunctive monitor thatprovides early identification and warning of critical metabolic imbalances or tissue viability and endpoint of resuscitation. These early warning changes are in advance of current critical-care monitors' ability to detect physiological changes at the tissue level, allowing the clinician to make more refined corrective medical actions.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is CritiSense's primary focus in terms of technology development?
- CritiSense develops technology for real-time monitoring of patients' metabolic state and as an endpoint of resuscitation.
- What is the name of CritiSense's first-generation product?
- CritiSense's first-generation product is called CritiView.
- What kind of information does CritiView provide?
- CritiView is a patient-monitoring system that provides real-time continuous information via four physiological parameters, sensed at the tissue level, reflecting the systemic metabolic state.
- What specific physiological functions does CritiView monitor at the tissue and cellular level?
- CritiView monitors mitochondrial function, microcirculatory blood flow, and oxygen saturation to provide continuous, real-time, multi-parametric physiological data.
- What is the main benefit of CritiView for clinicians?
- CritiView provides early identification and warning of critical metabolic imbalances or tissue viability and endpoint of resuscitation, allowing clinicians to make more refined corrective medical actions earlier than current critical-care monitors.
- When was CritiSense founded?
- CritiSense was founded in January 2004.
- What is the current operational status of CritiSense?
- CritiSense is currently inactive as of November 2016.
- How many employees does CritiSense have?
- CritiSense has 6 employees.
- What is CritiSense's primary business model?
- CritiSense operates with B2G and B2B business models.